Form 4 Tracker
Ginkgo Bioworks Holdings, Inc.
DNA

21 insider filings · Latest: Oct 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 10, 2025Jun 10 2:07 PMChe Austin
Proposed Sale
99$7.99$791—

View →

Jun 9, 2025Jun 9 2:01 PMChe Austin
Proposed Sale
99$7.75$767—

View →

Jun 6, 2025Jun 6 2:05 PMChe Austin
Proposed Sale
99$7.32$725—

View →

Jun 5, 2025Jun 5 2:20 PMChe Austin
Proposed Sale
99$7.60$752—

View →

Jun 4, 2025Jun 4 2:26 PMChe Austin
Proposed Sale
99$7.55$747—

View →

Jun 3, 2025Jun 3 2:08 PMChe Austin
Proposed Sale
99$7.27$720—

View →

Jun 2, 2025Jun 2 1:47 PMChe Austin
Proposed Sale
99$6.97$690—

View →

May 30, 2025May 30 1:40 PMChe Austin
Proposed Sale
99$7.12$705—

View →

May 29, 2025May 29 1:37 PMChe Austin
Proposed Sale
99$7.62$754—

View →

May 28, 2025May 28 1:36 PMChe Austin
Proposed Sale
99$6.96$689—

View →

May 27, 2025May 27 3:00 PMChe Austin
Proposed Sale
99$7.20$713—

View →

May 23, 2025May 23 1:55 PMChe Austin
Proposed Sale
99$6.75$668—

View →

May 22, 2025May 22 1:54 PMChe Austin
Proposed Sale
99$7.15$708—

View →

May 21, 2025May 21 8:11 PMDmytruk Mark E.
Proposed Sale
706$7.58$5.4K—

View →

May 21, 2025May 21 1:54 PMChe Austin
Proposed Sale
99$7.86$778—

View →

May 20, 2025May 20 1:41 PMChe Austin
Proposed Sale
99$8.10$802—

View →

May 19, 2025May 19 3:03 PMChe Austin
Proposed Sale
99$7.70$762—

View →

May 16, 2025May 16 1:40 PMChe Austin
Proposed Sale
99$7.72$764—

View →

May 15, 2025May 15 2:57 PMChe Austin
Proposed Sale
99$7.73$765—

View →

May 14, 2025May 14 2:18 PMChe Austin
Proposed Sale
99$8.01$793—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 21, 2026Aug 25 9:01 PMSteven P. CoenChief Financial Officer
Option Exercise
743—2,975(D)

View →

Jul 28, 2026Jul 30 8:28 PMBarry Canton10% Owner
Grant/Award
319,332—127,423(I)

View →

Jul 28, 2026Jul 30 8:27 PMReshma P. ShettyDirector, President & Founder, 10% Owner
Grant/Award
319,332—117,135(I)

View →

Jul 28, 2026Jul 30 8:26 PMJason R KellyDirector, Chief Executive Officer & Founder
Grant/Award
383,725—309,467(D)

View →

Jul 16, 2026Jul 20 9:00 PMSteven P. CoenChief Financial Officer
Option Exercise
1,486—3,131(D)

View →

Jun 11, 2026Jun 15 9:05 PMChristian O HenryDirector
Grant/Award
25,000—25,000(D)

View →

Jun 11, 2026Jun 15 9:04 PMRoss FubiniDirector
Grant/Award
25,000—25,000(D)

View →

Jun 11, 2026Jun 15 9:03 PMSri KosuriDirector
Grant/Award
25,000—25,000(D)

View →

Jun 11, 2026Jun 15 9:02 PMHarry SloanDirector
Grant/Award
25,000—25,000(D)

View →

May 21, 2026May 26 9:04 PMSteven P. CoenChief Financial Officer
Option Exercise
743—3,443(D)

View →

Apr 16, 2026Apr 20 9:02 PMSteven P. CoenChief Financial Officer
Option Exercise
743—3,599(D)

View →

Apr 10, 2026Apr 14 9:00 PMSteven P. CoenChief Financial Officer
Option Exercise
73,921—0(D)

View →

Apr 9, 2026Apr 13 9:00 PMBarry Canton10% Owner
Option Exercise
251,786—0(I)

View →

Apr 9, 2026Apr 13 9:00 PMReshma P. ShettyDirector, President & Founder, 10% Owner
Option Exercise
251,786—0(D)

View →

Apr 8, 2026Apr 10 9:02 PMReshma P. ShettyDirector, President & Founder, 10% Owner
Option Exercise
27,738—0(I)

View →

Apr 7, 2026Apr 10 9:02 PMReshma P. ShettyDirector, President & Founder, 10% Owner
Option Exercise
27,738—27,738(I)

View →

Apr 8, 2026Apr 10 9:01 PMBarry Canton10% Owner
Option Exercise
27,738—0(D)

View →

Apr 7, 2026Apr 10 9:01 PMBarry Canton10% Owner
Option Exercise
27,738—27,738(D)

View →

Apr 8, 2026Apr 10 9:01 PMJason R KellyDirector, CEO & Founder
Option Exercise
212,949—0(D)

View →

Apr 7, 2026Apr 10 9:01 PMJason R KellyDirector, CEO & Founder
Option Exercise
212,949—212,949(D)

View →

Page 1 of 2

Next →